Current strategies to combat the extraluminal route of infection are focused on Exit Site Management, or ESM.
A long-term Central Venous Catheter (CVC) to reduce CRBSI by eliminating the exit site as route of infection.
Partners
Marvao Medical’s manufacturing partner for NexSitetm technology is Harmac Medical. For more information on Harmac please visit www.harmac.com